How Actuate ACTU maintains its competitive edge Actuate posts 28 EPS upside on narrower Q4 loss ARK Innovation ETF ARKK Strategic Accumulation of Intellia Therapeutics NTLA Amid 95 Peak Drawdown and Phase 3 Catalysts First Trust Natural Gas ETF FCG Investment Viability Assessment for Natural Gas Sector Exposure How does Thor Industries THO manage costs Investors Pile In 20260501 Afya Q1 2026 Earnings EPS Misses Estimates Stock Edges Lower Purple Innovation PRPL Q1 2026 Earnings Small EPS Beat Fails to Lift Shares Amid Revenue Disclosures RDWR Q1 2026 Earnings EPS Misses Estimates Despite Positive Stock Reaction GECCI Q1 2026 Earnings EPS Surges Past Estimates as Investment Income Strengthens SPRY Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Continues RD Investment SACH Q4 2025 Earnings EPS Surges Past Estimates with 782 Beat But Stock Declines